Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4539308
Max Phase: Preclinical
Molecular Formula: C25H23ClN2O3
Molecular Weight: 434.92
Molecule Type: Unknown
Associated Items:
ID: ALA4539308
Max Phase: Preclinical
Molecular Formula: C25H23ClN2O3
Molecular Weight: 434.92
Molecule Type: Unknown
Associated Items:
Canonical SMILES: COC(=O)[C@H](Cc1c[nH]c2ccccc12)NC(=O)/C=C/C1=C(Cl)c2ccccc2CC1
Standard InChI: InChI=1S/C25H23ClN2O3/c1-31-25(30)22(14-18-15-27-21-9-5-4-7-19(18)21)28-23(29)13-12-17-11-10-16-6-2-3-8-20(16)24(17)26/h2-9,12-13,15,22,27H,10-11,14H2,1H3,(H,28,29)/b13-12+/t22-/m0/s1
Standard InChI Key: USXQWEXBYXTNBJ-GNNUASRNSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Unknown | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 434.92 | Molecular Weight (Monoisotopic): 434.1397 | AlogP: 4.52 | #Rotatable Bonds: 6 |
Polar Surface Area: 71.19 | Molecular Species: NEUTRAL | HBA: 3 | HBD: 2 |
#RO5 Violations: 0 | HBA (Lipinski): 5 | HBD (Lipinski): 2 | #RO5 Violations (Lipinski): 0 |
CX Acidic pKa: 12.84 | CX Basic pKa: | CX LogP: 4.47 | CX LogD: 4.47 |
Aromatic Rings: 3 | Heavy Atoms: 31 | QED Weighted: 0.44 | Np Likeness Score: 0.02 |
1. Rath SK, Singh S, Kumar S, Wani NA, Rai R, Koul S, Khan IA, Sangwan PL.. (2019) Synthesis of amides from (E)-3-(1-chloro-3,4-dihydronaphthalen-2-yl)acrylic acid and substituted amino acid esters as NorA efflux pump inhibitors of Staphylococcus aureus., 27 (2): [PMID:30552006] [10.1016/j.bmc.2018.12.008] |
Source(1):